Double hybrid system based on gene silencing by transcriptional interference

Details for Australian Patent Application No. 2005298499 (hide)

Owner Aventis Pharma S.A.

Inventors Fournier, Alain; Behrens, Ralf; Bandiera, Silvio

Agent A J Park

Pub. Number AU-A-2005298499

PCT Pub. Number WO2006/045941

Priority 0411372 25.10.04 FR

Filing date 24 October 2005

Wipo publication date 4 May 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 15/65 (2006.01) Mutation or genetic engineering - using markers

C12N 15/81 (2006.01) Mutation or genetic engineering - for yeasts

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/045941 Priority application(s): WO2006/045941

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298507-Modular humeral prosthesis for an inverse shoulder prosthesis

2005298494-System and method for carrying out fibered multiphoton microscopic imagery of a sample